Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
The duodenal-jejunal bypass liner (DJBL) is an endoscopic treatment for patients with type 2 diabetes mellitus (T2DM) and (morbid) obesity. The aim of the current study was to determine its efficacy and safety profile.